Analysis of oral microbeta in oral and upper digestive tract cancer patients

Analysis of oral microbeta in oral and upper digestive tract cancer patients - Analysis of oral microbeta in oral and upper digestive tract cancer patients

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000032116

Enrollment

300

Registered

2018-04-05

Start date

2016-10-19

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Oral and upper digestive tract cancer

Interventions

Swab

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Cancer patients(oral and upper digestive tract) and non-cancer patients.

Exclusion criteria

Exclusion criteria: The people can not follow instructions ,low secretional capacity of saliva . The people received chemotherapy and radiation. The people were adoministrated antimicrobial agent up to 28days.

Design outcomes

Primary

Measure	Time frame
Fungal species,Microbiota,The number of fungi, Concentration of each antimicrobial protein and antibody(Defensin,SLPI,Lactoferrin,Histatins,sIgA),Low-molecular substance	—

Secondary

Measure	Time frame
Age,Sex,Histoey of present illnesss,Past medical History ,Oral examination	—

Countries

Japan

Contacts

Public ContactTomoko Ohshima

Tsurumi University School of Dental Medicine Oral Microbiology

ohshima-t@fs.tsurumi-u.ac.jp045-580-8441

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026